Results 41 to 50 of about 1,281,063 (293)

Randomized, controlled clinical trial to evaluate efficacy of sticky bone and concentrated growth factor in the management of intrabony defects: 12 months follow-up study

open access: yesDental Research Journal, 2022
Background: Platelet derivatives are enriched growth factors that ameliorate various cellular processes in regeneration. The present clinical trial aimed to evaluate and compare the effects of sticky bone and concentrated growth factors (CGFs) in the ...
Dhanashree Ghoderao   +4 more
doaj   +1 more source

Concentrated growth factors (CGF): morphological and biochemical characterization

open access: yes, 2015
Italian Journal of Anatomy and Embryology, Vol. 120, No.
Bonazza, V   +4 more
openaire   +2 more sources

Factors Affecting Insulin-Like Growth Factor-I Concentration in Bovine Milk

open access: yesJournal of Dairy Science, 1991
To establish the naturally occurring range of insulin-like growth factor-I concentrations in bovine milk, samples from individual cows (n = 409) managed on five Missouri dairy herds were assayed. Parity, stage of lactation, and farm affected milk insulin-like growth factor-I concentration.
R J, Collier   +8 more
openaire   +2 more sources

Concentrations of Hepatocyte Growth Factor, Basic Fibroblast Growth Factor, and Vascular Endothelial Growth Factor in Pericardial Fluid and Plasma

open access: yesJapanese Heart Journal, 2004
Some angiogenic factors, including hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF), have been reported to promote angiogenesis and improve myocardial perfusion in experimental models of ischemic heart disease. These factors are produced in various tissues, including myocardium.
Tetsuya, Kubota   +6 more
openaire   +3 more sources

Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders [PDF]

open access: yesActa Medica (Hradec Kralove, Czech Republic), 2005
Angiogenesis plays a major role in the development and progression of haematological malignancies. In our study we measured plasma concentrations of key angiogenic activators vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) using comercially available sandwich enzyme-linked immunosorbent assay (ELISA) in 37 patients ...
Lukás, Smolej   +4 more
openaire   +3 more sources

Extraction of totally impacted lower third molar with CGF (concentrated growth factors) application into a post-extraction bone defect – a case report

open access: yesJournal of Education, Health and Sport, 2019
Concentrated Growth Factors (CGF) are obtained after blood collecting and its centrifuging. As an autogenic material it gains an advantage over xenogeneic materials used in regenerative procedures.
Adrian Gnatek   +3 more
doaj   +3 more sources

The Appliance of A-PRF and CGF in the Treatment of Impacted Mandibular Third Molar Extraction Sockets—Narrative Review

open access: yesApplied Sciences, 2022
Tooth extractions, especially of impacted lower third molars, are among the most common procedures performed in dental practices. The continuity of the patient’s oral mucosa, which is interrupted during them, can manifest itself in general discomfort ...
Daniel Selahi   +6 more
doaj   +1 more source

Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies [PDF]

open access: yesMolecular Human Reproduction, 2001
Vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) are considered to play important roles in angiogenesis and vascular permeability during placental development. Since trisomy 21 placentae show trophoblastic hypoplasia and hypovascularity, we investigated PLGF and VEGF synthesis in Down's syndrome pregnancies.
F, Debieve   +4 more
openaire   +2 more sources

Minimally invasive treatments revitalizing facial skin - a case study

open access: yesJournal of Medical Science, 2018
The increasing longevity of today’s societies has created a considerable need for the revitalization of facial skin undergoing the ageing processes. It is important to undertake preventive measures and start therapy when the first signs of ageing appear.
Teresa Matthews-Brzozowska   +4 more
doaj   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy